Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Collegian (Royal College of Nursing, Australia)
|
August 25, 2020
Mobile methods: Altering research data collection methods during COVID-19 and the unexpected benefits
Therese Burke, Joanna Patching
Research and Theory for Nursing Practice
|
October 17, 2019
"Taming the Beast": Exploring the Lived Experience of Relapsing Remitting Multiple Sclerosis Using a Life History Approach
Therese Burke, Steve Vucic, Joanna Patching
International Journal of MS Care
|
January 24, 2014
The evolving role of the multiple sclerosis nurse: an international perspective
Therese Burke, Sara Dishon, Lynn McEwan, et al.
Australian Journal of General Practice
|
April 1, 2022
The lived experience of multiple sclerosis: Patient insights to guide general practitioner care
Therese Burke, Rohan Greenland, Erin Brady, et al.
Australian Nursing & Midwifery Journal
|
March 29, 2014
Multiple sclerosis
Therese Burke, Kaye Hooper, Sharon Barlow, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 6, 2013
The utility of multimodal evoked potentials in multiple sclerosis prognostication
Sudarshini Ramanathan, Kerry Lenton, Therese Burke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 4, 2011
Cortical dysfunction underlies disability in multiple sclerosis
Steve Vucic, Therese Burke, Kerry Lenton, et al.
Pathology
|
March 13, 2012
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis
Ming-Wei Lin, Dan Suan, Kerry Lenton, et al.
Multiple Sclerosis and Related Disorders
|
August 28, 2023
The multiple sclerosis self-concept change scale: Development and validation of a new measure
Holly Emery, Ingrid van der Mei, Christine Padgett, et al.
Clinical Immunology (Orlando, Fla.)
|
January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies
Fiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Collegian (Royal College of Nursing, Australia)
|
August 25, 2020
Mobile methods: Altering research data collection methods during COVID-19 and the unexpected benefits
Therese Burke, Joanna Patching
Research and Theory for Nursing Practice
|
October 17, 2019
"Taming the Beast": Exploring the Lived Experience of Relapsing Remitting Multiple Sclerosis Using a Life History Approach
Therese Burke, Steve Vucic, Joanna Patching
International Journal of MS Care
|
January 24, 2014
The evolving role of the multiple sclerosis nurse: an international perspective
Therese Burke, Sara Dishon, Lynn McEwan, et al.
Australian Journal of General Practice
|
April 1, 2022
The lived experience of multiple sclerosis: Patient insights to guide general practitioner care
Therese Burke, Rohan Greenland, Erin Brady, et al.
Australian Nursing & Midwifery Journal
|
March 29, 2014
Multiple sclerosis
Therese Burke, Kaye Hooper, Sharon Barlow, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
|
July 6, 2013
The utility of multimodal evoked potentials in multiple sclerosis prognostication
Sudarshini Ramanathan, Kerry Lenton, Therese Burke, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
October 4, 2011
Cortical dysfunction underlies disability in multiple sclerosis
Steve Vucic, Therese Burke, Kerry Lenton, et al.
Pathology
|
March 13, 2012
Differentiating patterns of oligoclonal banding in the cerebrospinal fluid improves diagnostic utility for multiple sclerosis
Ming-Wei Lin, Dan Suan, Kerry Lenton, et al.
Multiple Sclerosis and Related Disorders
|
August 28, 2023
The multiple sclerosis self-concept change scale: Development and validation of a new measure
Holly Emery, Ingrid van der Mei, Christine Padgett, et al.
Clinical Immunology (Orlando, Fla.)
|
January 15, 2016
The low EOMES/TBX21 molecular phenotype in multiple sclerosis reflects CD56+ cell dysregulation and is affected by immunomodulatory therapies
Fiona C McKay, Prudence N Gatt, Nicole Fewings, et al.
Page
of 1